News & Events

All the latest news and events from PhoreMost

PhoreMost closes £33M ($46M) Series B financing
23rd March 2021

PhoreMost closes £33M ($46M) Series B financing

Funding to support progression of PLK1 program, for treatment of brain cancer, into the clinic within 18 months Company is advancing its pipeline of novel therapies for oncology and diseases of ageing, and developing novel therapeutic modalities in the targeted protein degradation space Oversubscribed investment round led by BGF, with XtalPi, Astellas Venture Management, Trend Investment Group, …